Glucose tolerance during pulmonary exacerbations in children with cystic fibrosis.

BACKGROUND: Patients with Cystic Fibrosis (CF) are relatively insulinopenic and are at risk of diabetes, especially during times of stress. There is a paucity of data in the literature describing glucose tolerance during CF pulmonary exacerbations. We hypothesised that glucose tolerance would be wor...

Full description

Bibliographic Details
Main Authors: John Widger, Mark R Oliver, Michele O'Connell, Fergus J Cameron, Sarath Ranganathan, Phil J Robinson
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3441597?pdf=render
id doaj-250827a930514ba998a28b186a3c15cd
record_format Article
spelling doaj-250827a930514ba998a28b186a3c15cd2020-11-25T01:08:22ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0179e4484410.1371/journal.pone.0044844Glucose tolerance during pulmonary exacerbations in children with cystic fibrosis.John WidgerMark R OliverMichele O'ConnellFergus J CameronSarath RanganathanPhil J RobinsonBACKGROUND: Patients with Cystic Fibrosis (CF) are relatively insulinopenic and are at risk of diabetes, especially during times of stress. There is a paucity of data in the literature describing glucose tolerance during CF pulmonary exacerbations. We hypothesised that glucose tolerance would be worse during pulmonary exacerbations in children with CF than during clinical stability. METHODS: Patients with CF, 10 years or older, admitted with a pulmonary exacerbation underwent an OGTT within 48 hours of admission. A repeat OGTT was performed 4 to 6 weeks post discharge when the patients were well. RESULTS: Nine patients completed the study. Four patients were found to have normal glucose tolerance, 3 with impaired and 2 with CF related diabetes during the exacerbation. Mean change in 2-hour glucose was 1.1 mmol (SD = 0.77). At the follow up OGTT, 8 of 9 (89%) remained within their respective glucose tolerance status groupings. CONCLUSION: The findings of this study show that there is little difference in glucose tolerance during CF exacerbations compared to clinical stability in the majority of patients.http://europepmc.org/articles/PMC3441597?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author John Widger
Mark R Oliver
Michele O'Connell
Fergus J Cameron
Sarath Ranganathan
Phil J Robinson
spellingShingle John Widger
Mark R Oliver
Michele O'Connell
Fergus J Cameron
Sarath Ranganathan
Phil J Robinson
Glucose tolerance during pulmonary exacerbations in children with cystic fibrosis.
PLoS ONE
author_facet John Widger
Mark R Oliver
Michele O'Connell
Fergus J Cameron
Sarath Ranganathan
Phil J Robinson
author_sort John Widger
title Glucose tolerance during pulmonary exacerbations in children with cystic fibrosis.
title_short Glucose tolerance during pulmonary exacerbations in children with cystic fibrosis.
title_full Glucose tolerance during pulmonary exacerbations in children with cystic fibrosis.
title_fullStr Glucose tolerance during pulmonary exacerbations in children with cystic fibrosis.
title_full_unstemmed Glucose tolerance during pulmonary exacerbations in children with cystic fibrosis.
title_sort glucose tolerance during pulmonary exacerbations in children with cystic fibrosis.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description BACKGROUND: Patients with Cystic Fibrosis (CF) are relatively insulinopenic and are at risk of diabetes, especially during times of stress. There is a paucity of data in the literature describing glucose tolerance during CF pulmonary exacerbations. We hypothesised that glucose tolerance would be worse during pulmonary exacerbations in children with CF than during clinical stability. METHODS: Patients with CF, 10 years or older, admitted with a pulmonary exacerbation underwent an OGTT within 48 hours of admission. A repeat OGTT was performed 4 to 6 weeks post discharge when the patients were well. RESULTS: Nine patients completed the study. Four patients were found to have normal glucose tolerance, 3 with impaired and 2 with CF related diabetes during the exacerbation. Mean change in 2-hour glucose was 1.1 mmol (SD = 0.77). At the follow up OGTT, 8 of 9 (89%) remained within their respective glucose tolerance status groupings. CONCLUSION: The findings of this study show that there is little difference in glucose tolerance during CF exacerbations compared to clinical stability in the majority of patients.
url http://europepmc.org/articles/PMC3441597?pdf=render
work_keys_str_mv AT johnwidger glucosetoleranceduringpulmonaryexacerbationsinchildrenwithcysticfibrosis
AT markroliver glucosetoleranceduringpulmonaryexacerbationsinchildrenwithcysticfibrosis
AT micheleoconnell glucosetoleranceduringpulmonaryexacerbationsinchildrenwithcysticfibrosis
AT fergusjcameron glucosetoleranceduringpulmonaryexacerbationsinchildrenwithcysticfibrosis
AT sarathranganathan glucosetoleranceduringpulmonaryexacerbationsinchildrenwithcysticfibrosis
AT philjrobinson glucosetoleranceduringpulmonaryexacerbationsinchildrenwithcysticfibrosis
_version_ 1725182927536390144